Resultados de procura - Tonia Cenci
- Mostrando 1 - 14 Resultados de 14
-
1
-
2
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation por Luciana Teofili, Maurizio Martini, Tonia Cenci, Giovanna Petrucci, Lorenza Torti, Sergio Storti, Francesco Guidi, Giuseppe Leone, Luigi Maria Larocca
Publicado 2007Artigo -
3
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis por Maurizio Martini, Luciana Teofili, Tonia Cenci, F. Giona, L. Torti, Massimiliano Rea, Robin Foà, Giuseppe Leone, Luigi Maria Larocca
Publicado 2008Artigo -
4
Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms por Luciana Teofili, Maurizio Martini, Maria Grazia Iachininoto, Sara Capodimonti, Eugenia Rosa Nuzzolo, Lorenza Torti, Tonia Cenci, Luigi Maria Larocca, Giuseppe Leone
Publicado 2011Artigo -
5
Markers of Myeloproliferative Diseases in Childhood Polycythemia Vera and Essential Thrombocythemia por Luciana Teofili, Fiorina Giona, Maurizio Martini, Tonia Cenci, Francesco Guidi, Lorenza Torti, Giovanna Palumbo, Angela Amendola, Robin Foà, Luigi Maria Larocca
Publicado 2007Artigo -
6
Diagnostic and prognostic value of immunocytochemistry and BRAF mutation analysis on liquid-based biopsies of thyroid neoplasms suspicious for carcinoma por Esther Diana Rossi, Maurizio Martini, Sara Capodimonti, Patrizia Straccia, Tonia Cenci, Celestino Pio Lombardi, Alfredo Pontecorvi, Luigi Maria Larocca, Guido Fadda
Publicado 2013Artigo -
7
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis por Roberto Pallini, Lucia Ricci‐Vitiani, Nicola Montano, Cristiana Mollinari, Mauro Biffoni, Tonia Cenci, Francesco Pierconti, Maurizio Martini, Ruggero De Maria, Luigi Maria Larocca
Publicado 2010Artigo -
8
Expression of EGFRvIII in Glioblastoma: Prognostic Significance Revisited por Nicola Montano, Tonia Cenci, Maurizio Martini, Quintino Giorgio D’Alessandris, Federica Pelacchi, Lucia Ricci‐Vitiani, Giulio Maira, Ruggero De Maria, Luigi Maria Larocca, Roberto Pallini
Publicado 2011Artigo -
9
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis por Luciana Teofili, Fiorina Giona, L. Torti, Tonia Cenci, Bianca Maria Ricerca, Carlo Rumi, Vinícius Tejada Nunes, Robin Foà, Giuseppe Leone, Maurizio Martini, Luigi Maria Larocca
Publicado 2009Artigo -
10
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience por Esther Diana Rossi, Maurizio Martini, Sara Capodimonti, Tonia Cenci, Patrizia Straccia, Basilio Angrisani, Costantino Ricci, Paola Lanza, Celestino Pio Lombardi, Alfredo Pontecorvi, Luigi Maria Larocca, Guido Fadda
Publicado 2014Artigo -
11
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors por Antonia Strippoli, Alessandra Cocomazzi, Michele Basso, Tonia Cenci, Riccardo Ricci, Francesco Pierconti, Alessandra Cassano, Vincenzo Fiorentino, Carlo Barone, Emilio Bria, Lucia Ricci‐Vitiani, Giampaolo Tortora, Luigi Maria Larocca, Maurizio Martini
Publicado 2020Artigo -
12
The Viral Load of Epstein–Barr Virus (EBV) DNA in Peripheral Blood Predicts for Biological and Clinical Characteristics in Hodgkin Lymphoma por Stefan Hohaus, Rosaria Santangelo, Manuela Giachelia, Barbara Vannata, Giuseppina Massini, Annarosa Cuccaro, Maurizio Martini, Valeriana Cesarini, Tonia Cenci, Francesco D’Alò, Maria Teresa Voso, Giovanni Fadda, Giuseppe Leone, Luigi Maria Larocca
Publicado 2011Artigo -
13
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response por Quintino Giorgio D’Alessandris, Mauro Biffoni, Maurizio Martini, Daniele Runci, Mariachiara Buccarelli, Tonia Cenci, Michele Signore, Louis F. Stancato, Alessandro Olivi, Ruggero De Maria, Luigi Maria Larocca, Lucia Ricci‐Vitiani, Roberto Pallini
Publicado 2016Artigo -
14
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation por Maria Alessandra Calegari, Alessandro Inno, Santa Monterisi, Armando Orlandi, Daniele Santini, Michele Basso, Alessandra Cassano, Maurizio Martini, Tonia Cenci, Ivana De Pascalis, Floriana Camarda, Brunella Barbaro, Luigi Maria Larocca, Stefania Gori, Giuseppe Tonini, Carlo Barone
Publicado 2017Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Biology
Internal medicine
Cancer research
Gene
Genetics
Immunology
Cancer
Pathology
Bone marrow
Oncology
Biochemistry
Essential thrombocythemia
Glioblastoma
Methylation
Molecular biology
Mutation
Myelofibrosis
Myeloproliferative Disorders
Temozolomide
Anagrelide
Colorectal cancer
Endocrinology
Environmental health
Epidermal growth factor receptor
Gene expression
Glioma
Immunohistochemistry
Methyltransferase
O-6-methylguanine-DNA methyltransferase